Point-of-care testing identifies ARDS inflammatory subphenotypes in real time, offering insights into patient prognosis and mortality risks.

Acute Respiratory Distress Syndrome (ARDS) is a critical condition that arises from a severe inflammatory response within the lungs, leading to widespread alveolar damage and respiratory failure.

Last week we started the conversation around “Is this an emergency?” by covering bloat (GDV) in dogs. This week, we’re ...

CHICAGO -- Classifying inflammatory subphenotypes of acute respiratory distress syndrome (ARDS) with bedside lab testing was feasible and showed differences in 60-day mortality, according to a ...

An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in ...

In a recent study published in PLoS ONE, researchers evaluated the outcomes and identified risk factors associated with the development of ARDS (acute respiratory distress syndrome) after SARS-CoV-2 ...

In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and ...

Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...

In-hospital mortality for MV-ARDS improved in the ICD-9-CM era but worsened in the ICD-10-CM era, when a more stringent ARDS definition was used.

This highly conserved protein is largely overlooked by researchers but is at the core of immune functions, helping regulate ...